Reliance Industries
Search results
Reliance Institute of Life Sciences (RILS), established and nurtured by Reliance Life Sciences (RLS), is an institution dedicated to providing postgraduate, doctoral research, professional and continuing education programs in various domains of life sciences and related technologies.
Reliance Life Sciences has catalyzed the emergence of regenerative medicine in the country, and has the highest experience with cord blood stem cell transplants in India. RLS is one of the few centres in the world offering a specialized range of tests in molecular medicine and molecular genetics.
Reliance Life Sciences is a diverse and integrated biotechnology initiative of the Reliance Group of companies, India's largest private sector enterprise.
Reliance Institute of Life Sciences (RILS), an institution of higher learning in various domains of life sciences and related technologies offers graduate, postgraduate, doctoral, research and continuing education programs in several emerging areas of science and technology.
Reliance Institute of Life Sciences (RILS), established by Dhirubhai Ambani Foundation, is an institution of higher education in various fields of life sciences and related technologies. [1]
The YEP focuses on building competency for designing, engineering, implementation, installation, commissioning and validation of a highly automated biopharmaceuticals manufacturing plant, compliant with the regulations of Indian FDA, USFDA and EMEA.
Here we mentioned some of the Accreditation of Reliance Life Sciences Policies.
Reliance Institute of Life Sciences (RILS) is a pharmaceuticals company based out of Dhirubhai Ambani Life Sciences Center Thane- Belapur Road, Rabale, Navi Mumbai, Maharashtra, India.
Aug 27, 2021 · The drug regulatory authority on Thursday approved Reliance Life Sciences, part of India's largest private sector enterprise-application, seeking to conduct clinical trials of its recombinant protein-based Covid-19 vaccine candidate.
Jul 31, 2023 · The first phase of the 160-acre campus of Reliance Life Sciences (RLS), a biotechnology company fully owned by the investment companies of Mukesh Ambani, is set to be ready in about a year.
